FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephan Krähenbühl

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Geographic Areas

Switzerland

Devices

Ligation

Disorders

Procedures

Drug Therapy, Combination

Phenomena

Oxidation-Reduction

Co-author Network

Publications

TOP 3
Natascha Wuillemin; Jacqueline Adam; Stefano Fontana; Stephan Krähenbühl; Werner J Pichler; Daniel Yerly
HLA Haplotype Determines Hapten or p-i T Cell Reactivity to Flucloxacillin.
Stephan Krähenbühl
[In Process Citation].
Andrea Felser; Kim Blum; Jamal Bouitbir; Peter W Lindinger; Stephan Krähenbühl
Mechanisms of hepatocellular toxicity associated with dronedarone--a comparison to amiodarone.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephan Krähenbühl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Natascha Wuillemin; Jacqueline Adam; Stefano Fontana; Stephan Krähenbühl; Werner J Pichler; Daniel Yerly
HLA Haplotype Determines Hapten or p-i T Cell Reactivity to Flucloxacillin.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(10):4956-64.
2013: Stephan Krähenbühl
[In Process Citation].
Therapeutische Umschau. Revue thérapeutique 2013;70(5):284-8.
2013: Andrea Felser; Kim Blum; Jamal Bouitbir; Peter W Lindinger; Stephan Krähenbühl
Mechanisms of hepatocellular toxicity associated with dronedarone--a comparison to amiodarone.
Toxicological sciences : an official journal of the Society of Toxicology 2013;131(2):480-90.
2012: Thi Thanh Thuy Pham; Hong Heng See; Stephan Krähenbühl; Réjane Morand; Peter C Hauser
Determination of free and total valproic acid in human plasma by capillary electrophoresis with contactless conductivity detection.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2012;907():74-8.
2012: Swarna Maseneni; Anne Barbara Taegtmeyer; Karin Brecht; Massimiliano Donzelli; Stephan Krähenbühl
Toxicity of clopidogrel and ticlopidine on human myeloid progenitor cells: importance of metabolites.
Toxicology 2012;299(2-3):139-45.
2012: Pascal Detampel; Mareike Beck; Stephan Krähenbühl; Jörg Huwyler
Drug interaction potential of resveratrol.
Drug metabolism reviews 2012;44(3):253-65.
2012: Hong Heng See; Stephan Krähenbühl; Réjane Morand; Worapan Pormsila; Julia Schmidt-Marzinkowski; Peter C Hauser
Determination of creatine and phosphocreatine in muscle biopsy samples by capillary electrophoresis with contactless conductivity detection.
Analytica chimica acta 2012;727():78-82.
2012: L Nezic; Stephan Krähenbühl; Alexandra E Rätz Bravo
[Diclofenac induced liver injuries].
Praxis 2012;101(6):371-9.
2011: Adrian Derungs; Stephan Krähenbühl; Hans H Maurer; Markus R Meyer; Simeon Schietzel; Matthias E Liechti
Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone).
Clinical toxicology (Philadelphia, Pa.) 2011;49(7):691-3.
2011: M Bruggisser; Alexandra E Rätz Bravo; Stephan Krähenbühl
[Severe pancytopenia and stomatitis in a patient treated with low-dose methostraxate].
Praxis 2011;100(13):765-74; quiz 772.
2011: Worapan Pormsila; Réjane Morand; Stephan Krähenbühl; Peter C Hauser
Capillary electrophoresis with contactless conductivity detection for the determination of carnitine and acylcarnitines in clinical samples.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2011;879(13-14):921-6.
2011: Worapan Pormsila; Réjane Morand; Stephan Krähenbühl; Peter C Hauser
Quantification of plasma lactate concentrations using capillary electrophoresis with contactless conductivity detection.
Electrophoresis 2011;32(8):884-9.
2011: C C Franz; M Bruggisser; Stephan Krähenbühl; Alexandra E Rätz Bravo
[Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole].
Praxis 2011;100(5):273-84.
2011: Jörg Halter; W M M Schüpbach; C Casali; R Elhasid; K Fay; S Hammans; I Illa; L Kappeler; Stephan Krähenbühl; T Lehmann; H Mandel; R Marti; Heinrich P Mattle; K Orchard; D Savage; C M Sue; D Valcarcel; Alois Gratwohl; M Hirano
Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.
Bone marrow transplantation 2011;46(3):330-7.
2011: Anja Zahno; Karin Brecht; Réjane Morand; Swarna Maseneni; Michael Török; Peter W Lindinger; Stephan Krähenbühl
The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells.
Biochemical pharmacology 2011;81(3):432-41.
2011: Oliver Kummer; Felix Hammann; Claudine Moser; Olivier Schaller; juergen Drewe; Stephan Krähenbühl
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.
European journal of clinical pharmacology 2011;67(1):63-71.
2010: Jean Grisouard; Katharina Timper; Tanja M Radimerski; Daniel M Frey; Ralph Peterli; Blerina Kola; Márta Korbonits; Paul Herrmann; Stephan Krähenbühl; Henryk Zulewski; Ulrich Keller; Beat Müller; Mirjam Christ-Crain
Mechanisms of metformin action on glucose transport and metabolism in human adipocytes.
Biochemical pharmacology 2010;80(11):1736-45.
2010: Anja Zahno; Karin Brecht; Michael Bodmer; Daniel Bur; Dimitrios A Tsakiris; Stephan Krähenbühl
Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro.
British journal of pharmacology 2010;161(2):393-404.
2010: Isabel Krämer; Christine Rauber-Lüthy; Hugo Kupferschmidt; Stephan Krähenbühl; Alessandro Ceschi
Minimal dose for severe poisoning and influencing factors in acute human clozapine intoxication: a 13-year retrospective study.
Clinical neuropharmacology 2010;33(5):230-4.
2010: Worapan Pormsila; Stephan Krähenbühl; Peter C Hauser
Determination of carnitine in food and food supplements by capillary electrophoresis with contactless conductivity detection.
Electrophoresis 2010;31(13):2186-91.
2010: S S Egger; S Meier; C Leu; S Christen; Alois Gratwohl; Stephan Krähenbühl; Manuel Haschke
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT.
Bone marrow transplantation 2010;45(7):1197-203.
2010: Regula Schürch; Liliane Todesco; Katarina Novakova; Meike Mevissen; Bruno Stieger; Stephan Krähenbühl
The plasma carnitine concentration regulates renal OCTN2 expression and carnitine transport in rats.
European journal of pharmacology 2010;635(1-3):171-6.
2010: Manuel Haschke; Katja Suter; Sarah Hofmann; Robert Witschi; Johannes Froehlich; Georgios Imanidis; juergen Drewe; Thomas A Briellmann; Franz E Dussy; Stephan Krähenbühl; Christian Surber
Pharmacokinetics and pharmacodynamics of nasally delivered midazolam.
British journal of clinical pharmacology 2010;69(6):607-16.
2010: Peter James Mullen; Barbara Lüscher; Hubert Scharnagl; Stephan Krähenbühl; Karin Brecht
Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy.
Biochemical pharmacology 2010;79(8):1200-9.
2010: M Sawatzki; Oliver Kummer; Stephan Krähenbühl; Martin Siegemund
[Seizure and non-cardiogenic pulmonary edema after intoxication].
Der Internist 2010;51(4):528-32.
2010: Manuel Haschke; Tanja Vitins; Saskia Lüde; Liliane Todesco; Katerina Novakova; Richard Herrmann; Stephan Krähenbühl
Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(2):426-33.
2010: Birk Poller; juergen Drewe; Stephan Krähenbühl; Jörg Huwyler; Heike Gutmann
Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier.
Cellular and molecular neurobiology 2010;30(1):63-70.
2009: Michael Bodmer; Yolanda B Brauchli; Stephan Krähenbühl; Susan S Jick; Christoph R Meier
Statin use and risk of gallstone disease followed by cholecystectomy.
JAMA : the journal of the American Medical Association 2009;302(18):2001-7.
2009: Oliver Kummer; Manuel Haschke; Felix Hammann; Michael Bodmer; Shirin Bruderer; Yann Regnault; Jasper Dingemanse; Stephan Krähenbühl
Comparison of the dissolution and pharmacokinetic profiles of two galenical formulations of the endothelin receptor antagonist macitentan.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2009;38(4):384-8.
2009: Liliane Todesco; Michael Bodmer; Karin Vonwil; Daniel Häussinger; Stephan Krähenbühl
Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2.
Chemico-biological interactions 2009;180(3):472-7.
2009: Chantal Schlatter; Sabin S Egger; Lydia Tchambaz; Stephan Krähenbühl
Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(7):561-78.
2009: Alexandra E Rätz Bravo; Silvia Hofer; Stephan Krähenbühl; Christian Ludwig
Fatal drug-drug interaction of brivudine and capecitabine.
Acta oncologica (Stockholm, Sweden) 2009;48(4):631-3.
2008: Birk Poller; Heike Gutmann; Stephan Krähenbühl; Babette Weksler; Ignacio Romero; Pierre-Olivier Couraud; Gerald Tuffin; juergen Drewe; Jörg Huwyler
The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies.
Journal of neurochemistry 2008;107(5):1358-68.
2008: K M Waldhauser; K Brecht; S Hebeisen; Huy Riem Ha; D Konrad; D Bur; Stephan Krähenbühl
Interaction with the hERG channel and cytotoxicity of amiodarone and amiodarone analogues.
British journal of pharmacology 2008;155(4):585-95.
2008: Bettina Link; Manuel Haschke; Nathalie Grignaschi; Michael Bodmer; Yvonne Zysset Aschmann; Markus Wenk; Stephan Krähenbühl
Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping.
British journal of clinical pharmacology 2008;66(4):473-84.
2008: Michael Bodmer; Thilo Burkard; Oliver Kummer; Ralf Beyrau; Stephan Krähenbühl; Manuel Haschke
Pharmacokinetics and pharmacodynamics of quetiapine in a patient with a massive overdose.
Therapeutic drug monitoring 2008;30(4):553-6.
2008: Andrea Botomino; Rudolf Bruppacher; Stephan Krähenbühl; Kurt E Hersberger
Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling in pharmacies.
Pharmacy world & science : PWS 2008;30(3):222-6.
2008: Liliane Todesco; D Bur; H Brooks; Michael Török; Lukas Landmann; Bruno Stieger; Stephan Krähenbühl
Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2.
Cellular and molecular life sciences : CMLS 2008;65(10):1596-608.
2008: Yolanda B Brauchli; Matthias Gittermann; Marc Michot; Stephan Krähenbühl; Hanspeter E Gnehm
A fatal tick bite occurring during the course of tick-borne encephalitis vaccination.
The Pediatric infectious disease journal 2008;27(4):363-5.
2008: Oliver Kummer; Felix Hammann; Michael Bodmer; K Novakova; Stephan Krähenbühl; Manuel Haschke
[Drug-induced toxic hepatitis].
Praxis 2008;97(5):235-9; quiz 240-1.
2008: Yolanda B Brauchli; André Scholer; Martin Schwietert; Stephan Krähenbühl
Undetectable phenytoin serum levels by an automated particle-enhanced turbidimetric inhibition immunoassay in a patient with monoclonal IgM lambda.
Clinica chimica acta; international journal of clinical chemistry 2008;389(1-2):174-6.
2008: Yvonne Zysset Aschmann; Oliver Kummer; André Linka; Markus Wenk; Andrea Azzola; Michael Bodmer; Stephan Krähenbühl; Manuel Haschke
Pharmacokinetics and pharmacodynamics of sildenafil in a patient treated with human immunodeficiency virus protease inhibitors.
Therapeutic drug monitoring 2008;30(1):130-4.
2008: Michael Bodmer; Bettina Link; Nathalie Grignaschi; Oliver Kummer; Stephan Ruegg; Manuel Haschke; Stephan Krähenbühl
Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam.
Therapeutic drug monitoring 2008;30(1):120-4.
2008: Andrea Caroline Knapp; Liliane Todesco; Konstantin Beier; Luigi Terracciano; Hans Sägesser; Jürg Reichen; Stephan Krähenbühl
Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores.
The Journal of pharmacology and experimental therapeutics 2008;324(2):568-75.
2008: Andrea Caroline Knapp; Liliane Todesco; Michael Torok; Konstantin Beier; Stephan Krähenbühl
Effect of carnitine deprivation on carnitine homeostasis and energy metabolism in mice with systemic carnitine deficiency.
Annals of nutrition & metabolism 2008;52(2):136-44.
2008: Saskia Lüde; Michael Török; Sandy Dieterle; René Jäggi; Karin Berger Büter; Stephan Krähenbühl
Hepatocellular toxicity of kava leaf and root extracts.
Phytomedicine : international journal of phytotherapy and phytopharmacology 2008;15(1-2):120-31.
2007: Laurent Haegeli; Hans Peter Brunner-La Rocca; Markus Wenk; Matthias Pfisterer; juergen Drewe; Stephan Krähenbühl
Sublingual administration of furosemide: new application of an old drug.
British journal of clinical pharmacology 2007;64(6):804-9.
2007: S Lüde; Michael Török; S Dieterle; A C Knapp; R Kaeufeler; R Jäggi; U Spornitz; Stephan Krähenbühl
Hepatic effects of Cimicifuga racemosa extract in vivo and in vitro.
Cellular and molecular life sciences : CMLS 2007;64(21):2848-57.
2007: Oliver Kummer; K Novakova; T Burkard; Felix Hammann; Stephan Krähenbühl; Michael Bodmer
[Drug-induced microscopic colitis].
Praxis 2007;96(35):1293-7.
2007: Michael Bodmer; Patrizia Amico; Michael J Mihatsch; Manuel Haschke; Oliver Kummer; Stephan Krähenbühl; Michael Mayr
Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(8):2366-70.
2007: Sabin S Egger; Alexandra E Rätz Bravo; Lorenzo Hess; Raymond G Schlienger; Stephan Krähenbühl
Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins.
Drugs & aging 2007;24(5):429-40.
2007: Anita Krähenbühl-Melcher; Raymond G Schlienger; Markus Lampert; Manuel Haschke; juergen Drewe; Stephan Krähenbühl
Drug-related problems in hospitals: a review of the recent literature.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(5):379-407.
2007: Bettina Link; Manuel Haschke; Markus Wenk; Stephan Krähenbühl
Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry.
Rapid communications in mass spectrometry : RCM 2007;21(9):1531-40.
2007: Jörg Indermitte; Sabine Burkolter; juergen Drewe; Stephan Krähenbühl; Kurt E Hersberger
Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(1):71-80.
2006: Priska Kaufmann; Manuel Haschke; Michael Török; Johannes Beltinger; Katrijn Bogman; Markus Wenk; Luigi Terracciano; Stephan Krähenbühl
Mechanisms of venoocclusive disease resulting from the combination of cyclophosphamide and roxithromycin.
Therapeutic drug monitoring 2006;28(6):766-74.
2006: Katri Maria Waldhauser; Michael Török; Huy Riem Ha; Urs Thomet; Daniel Konrad; Karin Brecht; Ferenc Follath; Stephan Krähenbühl
Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives.
The Journal of pharmacology and experimental therapeutics 2006;319(3):1413-23.
2006: Oliver Kummer; Manuel Haschke; D Tuchscherer; Markus Lampert; F Martius; Stephan Krähenbühl
[Agranulocytosis in a patient treated with metamizole and clopidogrel].
Praxis 2006;95(45):1743-5; quiz 1746-7.
2006: Priska Kaufmann; Michael Török; A Zahno; K M Waldhauser; K Brecht; Stephan Krähenbühl
Toxicity of statins on rat skeletal muscle mitochondria.
Cellular and molecular life sciences : CMLS 2006;63(19-20):2415-25.
2006: Michael Bodmer; Sabin S Egger; Elisabeth Hohenstein; Helmut Beltraminelli; Stephan Krähenbühl
Lichenoid eruption associated with the use of nebivolol.
The Annals of pharmacotherapy 2006;40(9):1688-90.
2006: Sabin S Egger; I Gehrig Studer; Alexandra E Rätz Bravo; Stephan Krähenbühl
[Minocycline-induced lupus erythematodes].
Praxis 2006;95(35):1297-303.
2006: Christoph Stettler; Sabin Allemann; Peter Jüni; Carole A Cull; Rury R Holman; Matthias Egger; Stephan Krähenbühl; Peter Diem
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
American heart journal 2006;152(1):27-38.
2006: Markus Wenk; Laurent Haegeli; Hanspeter Brunner; Stephan Krähenbühl
Determination of furosemide in plasma and urine using monolithic silica rod liquid chromatography.
Journal of pharmaceutical and biomedical analysis 2006;41(4):1367-70.
2006: Johannes Beltinger; Manuel Haschke; Priska Kaufmann; Marc Michot; Luigi Terracciano; Stephan Krähenbühl
Hepatic veno-occlusive disease associated with immunosuppressive cyclophosphamide dosing and roxithromycin.
The Annals of pharmacotherapy 2006;40(4):767-70.
2006: Markus Wenk; Armin Droll; Stephan Krähenbühl
Fast and reliable determination of the antifungal drug voriconazole in plasma using monolithic silica rod liquid chromatography.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2006;832(2):313-6.
2006: Alexandra E Rätz Bravo; Lydia Tchambaz; A Krähenbuhl-Melcher; Lorenzo Hess; Raymond G Schlienger; Stephan Krähenbühl
[Prevalence of potential drug-drug interactions in ambulatory patients with statin therapy].
Praxis 2006;95(5):139-46.
2006: Laurence Vernez; Michael Dickenmann; Jürg Steiger; Markus Wenk; Stephan Krähenbühl
Effect of L-carnitine on the kinetics of carnitine, acylcarnitines and butyrobetaine in long-term haemodialysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(2):450-8.
2006: C Becker; C Hvalic; G Delmore; Stephan Krähenbühl; Raymond G Schlienger
[Recurrent acute pancreatitis during pravastatin-therapy].
Praxis 2006;95(4):111-6.
2006: Sabin S Egger; Andrea Bachmann; Nathalie Hubmann; Raymond G Schlienger; Stephan Krähenbühl
Prevalence of potentially inappropriate medication use in elderly patients: comparison between general medical and geriatric wards.
Drugs & aging 2006;23(10):823-37.
2006: Michael Bodmer; Michael Sulz; Sylvia Stadlmann; Armin Droll; Luigi Terracciano; Stephan Krähenbühl
Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase.
Digestion 2006;74(1):28-32.
2006: Lydia Tchambaz; Chantal Schlatter; Max Jakob; Anita Krähenbühl; Peter Wolf; Stephan Krähenbühl
Dose adaptation of antineoplastic drugs in patients with liver disease.
Drug safety : an international journal of medical toxicology and drug experience 2006;29(6):509-22.
2006: Bernhard Straubhaar; Stephan Krähenbühl; Raymond G Schlienger
The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge.
Drug safety : an international journal of medical toxicology and drug experience 2006;29(1):79-90.
2006: Gabriela Grunder; Yvonne Zysset-Aschmann; Florence Vollenweider; Thomas Maier; Stephan Krähenbühl; juergen Drewe
Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.
Antimicrobial agents and chemotherapy 2006;50(1):68-72.
2005: Anita Krähenbühl-Melcher; Stephan Krähenbühl
[Hospital drug safety: medication errors and adverse drug reactions].
Praxis 2005;94(24-25):1031-8.
2005: Anita Schnyder; Stephan Krähenbühl; juergen Drewe; Jörg Huwyler
Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects.
Journal of drug targeting 2005;13(5):325-35.
2005: Sabin S Egger; Mikael G Sawatzki; juergen Drewe; Stephan Krähenbühl
Life-threatening hemorrhage after dalteparin therapy in a patient with impaired renal function.
Pharmacotherapy 2005;25(6):881-5.
2005: Priska Kaufmann; Michael Török; Anya Hänni; Paul Roberts; Rodolfo Gasser; Stephan Krähenbühl
Mechanisms of benzarone and benzbromarone-induced hepatic toxicity.
Hepatology (Baltimore, Md.) 2005;41(4):925-35.
2005: Sabin S Egger; Stephan Krähenbühl; Raymond G Schlienger
[Dealing with adverse drug reactions in dentistry. Procedures on encountering adverse drug reactions and goal of the Swiss Pharmacovigilance system].
Schweizer Monatsschrift für Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia / SSO 2005;115(12):1209-18.
2005: Irene Blanco; Stephan Krähenbühl; Raymond G Schlienger
Corticosteroid-associated tendinopathies: an analysis of the published literature and spontaneous pharmacovigilance data.
Drug safety : an international journal of medical toxicology and drug experience 2005;28(7):633-43.
2005: Fabiola Delcò; Lydia Tchambaz; Raymond G Schlienger; juergen Drewe; Stephan Krähenbühl
Dose adjustment in patients with liver disease.
Drug safety : an international journal of medical toxicology and drug experience 2005;28(6):529-45.
2005: Alexandra E Rätz Bravo; Lydia Tchambaz; Anita Krähenbühl-Melcher; Lorenzo Hess; Raymond G Schlienger; Stephan Krähenbühl
Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.
Drug safety : an international journal of medical toxicology and drug experience 2005;28(3):263-75.
2005: Alexandra E Rätz Bravo; juergen Drewe; Raymond G Schlienger; Stephan Krähenbühl; Hans Pargger; Wolfgang Ummenhofer
Hepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literature.
Critical care medicine 2005;33(1):128-34; discussion 245-6.
2004: Stephan Krähenbühl
[Pharmacokinetics and pharmacodynamices in the elderly].
Praxis 2004;93(33):1305-10.
2004: Stephan Krähenbühl
[Toxic liver injuries].
Therapeutische Umschau. Revue thérapeutique 2004;61(8):529-34.
2004: Alexandra E Rätz Bravo; Sabin S Egger; Sophie Crespo; Willi L Probst; Stephan Krähenbühl
Lithium intoxication as a result of an interaction with rofecoxib.
The Annals of pharmacotherapy 2004;38(7-8):1189-93.
2004: Markus Wenk; Liliane Todesco; Stephan Krähenbühl
Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females.
British journal of clinical pharmacology 2004;57(4):495-9.
2004: Laurence Vernez; Markus Wenk; Stephan Krähenbühl
Determination of carnitine and acylcarnitines in plasma by high-performance liquid chromatography/electrospray ionization ion trap tandem mass spectrometry.
Rapid communications in mass spectrometry : RCM 2004;18(11):1233-8.
2003: Nadia Affolter; Stephan Krähenbühl; Raymond G Schlienger
Appropriateness of serum level determinations of antiepileptic drugs.
Swiss medical weekly 2003;133(43-44):591-7.
2003: Liliane Todesco; Michael Török; Stephan Krähenbühl; Markus Wenk
Determination of -3858G-->A and -164C-->A genetic polymorphisms of CYP1A2 in blood and saliva by rapid allelic discrimination: large difference in the prevalence of the -3858G-->A mutation between Caucasians and Asians.
European journal of clinical pharmacology 2003;59(4):343-6.
2003: Stephan Krähenbühl
[Abuse of benzodiazepines and similar substances].
Therapeutische Umschau. Revue thérapeutique 2003;60(6):335-40.
2003: Christian E Zaugg; Markus Spaniol; Priska Kaufmann; Mohamed Bellahcene; Vânia Barbosa; M Tolnay; Peter T Buser; Stephan Krähenbühl
Myocardial function and energy metabolism in carnitine-deficient rats.
Cellular and molecular life sciences : CMLS 2003;60(4):767-75.
2003: Lukas Krähenbühl; Corinne Lang; Saskia Lüdes; Christian Seiler; Markus Schäfer; Arthur Zimmermann; Stephan Krähenbühl
Reduced hepatic glycogen stores in patients with liver cirrhosis.
Liver international : official journal of the International Association for the Study of the Liver 2003;23(2):101-9.
2003: Fatima Vrtic; Walter E Haefeli; juergen Drewe; Stephan Krähenbühl; Markus Wenk
Interaction of ibuprofen and probenecid with drug metabolizing enzyme phenotyping procedures using caffeine as the probe drug.
British journal of clinical pharmacology 2003;55(2):191-8.
2003: Laurence Vernez; Gérard Hopfgartner; Markus Wenk; Stephan Krähenbühl
Determination of carnitine and acylcarnitines in urine by high-performance liquid chromatography-electrospray ionization ion trap tandem mass spectrometry.
Journal of chromatography. A 2003;984(2):203-13.
2003: Markus Spaniol; Priska Kaufmann; Konstantin Beier; Jenny Wüthrich; Michael Török; Hubert Scharnagl; Winfried März; Stephan Krähenbühl
Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate.
Journal of lipid research 2003;44(1):144-53.
2003: Andreas Tietz; Markus H Heim; Urs Eriksson; Stephan Marsch; Luigi Terracciano; Stephan Krähenbühl
Fulminant liver failure associated with clarithromycin.
The Annals of pharmacotherapy 2003;37(1):57-60.
2002: Christoph R Meier; Stephan Krähenbühl; Raymond G Schlienger; Hershel Jick
Association between body mass index and liver disorders: an epidemiological study.
Journal of hepatology 2002;37(6):741-7.
2002: Corinne Lang; Simona Berardi; Markus Schäfer; Dolors Serra; Fausto G Hegardt; Lukas Krähenbühl; Stephan Krähenbühl
Impaired ketogenesis is a major mechanism for disturbed hepatic fatty acid metabolism in rats with long-term cholestasis and after relief of biliary obstruction.
Journal of hepatology 2002;37(5):564-71.
2002: Mara R Mordasini; Stephan Krähenbühl; Raymond G Schlienger
Appropriateness of digoxin level monitoring.
Swiss medical weekly 2002;132(35-36):506-12.
2002: Raymond G Schlienger; Martin J Keller; Stephan Krähenbühl
Tolterodine-associated acute mixed liver injury.
The Annals of pharmacotherapy 2002;36(5):817-9.
2002: Sandra Wächter; Michael Vogt; Roland Kreis; Chris Boesch; Peter Bigler; Hans Hoppeler; Stephan Krähenbühl
Long-term administration of L-carnitine to humans: effect on skeletal muscle carnitine content and physical performance.
Clinica chimica acta; international journal of clinical chemistry 2002;318(1-2):51-61.
2001: H Brooks; Stephan Krähenbühl
Identification and tissue distribution of two differentially spliced variants of the rat carnitine transporter OCTN2.
FEBS letters 2001;508(2):175-80.
2001: Markus Spaniol; R Bracher; Huy Riem Ha; Ferenc Follath; Stephan Krähenbühl
Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria.
Journal of hepatology 2001;35(5):628-36.
2001: Christina Quattropani; M Schneider; A Helbling; Arthur Zimmermann; Stephan Krähenbühl
Cholangiopathy after short-term administration of piperacillin and imipenem/cilastatin.
Liver 2001;21(3):213-6.
2001: Markus Spaniol; H Brooks; L Auer; A Zimmermann; Marc Solioz; Bruno Stieger; Stephan Krähenbühl
Development and characterization of an animal model of carnitine deficiency.
European journal of biochemistry / FEBS 2001;268(6):1876-87.
2001: Corinne Lang; Markus Schäfer; D Serra; Fausto G Hegardt; Lukas Krähenbühl; Stephan Krähenbühl
Impaired hepatic fatty acid oxidation in rats with short-term cholestasis: characterization and mechanism.
Journal of lipid research 2001;42(1):22-30.
2000: Laurence Vernez; Wolfgang Thormann; Stephan Krähenbühl
Analysis of carnitine and acylcarnitines in urine by capillary electrophoresis.
Journal of chromatography. A 2000;895(1-2):309-16.
2000: Lukas Krähenbühl; Monika Ledermann; Corinne Lang; Stephan Krähenbühl
Relationship between hepatic mitochondrial functions in vivo and in vitro in rats with carbon tetrachloride-induced liver cirrhosis.
Journal of hepatology 2000;33(2):216-23.
2000: Stephan Krähenbühl; Sebastian Brandner; S Kleinle; S Liechti; D Straumann
Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure.
Liver 2000;20(4):346-8.
2000: Simona Berardi; Bruno Stieger; B Hagenbuch; Ernesto Carafoli; Stephan Krähenbühl
Characterization of L-carnitine transport into rat skeletal muscle plasma membrane vesicles.
European journal of biochemistry / FEBS 2000;267(7):1985-94.
2000: H Brooks; Stephan Krähenbühl
Development of a new assay for complex I of the respiratory chain.
Clinical chemistry 2000;46(3):345-50.
1999: Lukas Krähenbühl; B Hagenbuch; Simona Berardi; Markus Schäfer; Stephan Krähenbühl
Rapid normalization of hepatic glycogen metabolism in rats with long-term bile duct ligation after biliodigestive anastomosis.
Journal of hepatology 1999;31(4):656-63.
1999: Stephan Krähenbühl; S Kleinle; S Henz; Kurt Leibundgut; S Liechti; Arthur Zimmermann; Ulrich N Wiesmann
Microvesicular steatosis, hemosiderosis and rapid development of liver cirrhosis in a patient with Pearson's syndrome.
Journal of hepatology 1999;31(3):550-5.
1999: S Wächter; Lukas Krähenbühl; M Schäfer; Stephan Krähenbühl
The liver carnitine pool reflects alterations in hepatic fatty acid metabolism in rats with bile duct ligation before and after biliodigestive anastomosis.
Journal of hepatology 1999;30(2):242-8.
1999: Stephan Krähenbühl; B Willer; Pius Brühlmann; H Hoppeler; Gerold Stucki
Carnitine homeostasis in patients with rheumatoid arthritis.
Clinica chimica acta; international journal of clinical chemistry 1999;279(1-2):35-45.
1998: W Heuberger; S Berardi; E Jacky; P Pey; Stephan Krähenbühl
Increased urinary excretion of carnitine in patients treated with cisplatin.
European journal of clinical pharmacology 1998;54(7):503-8.
1998: S Kleinle; V Schneider; P Moosmann; Sebastian Brandner; Stephan Krähenbühl; S Liechti-Gallati
A novel mitochondrial tRNA(Phe) mutation inhibiting anticodon stem formation associated with a muscle disease.
Biochemical and biophysical research communications 1998;247(1):112-5.
1998: Lukas Krähenbühl; M Schäfer; Stephan Krähenbühl
Reversibility of hepatic mitochondrial damage in rats with long-term cholestasis.
Journal of hepatology 1998;28(6):1000-7.
1998: H H Kupferschmidt; Karin Fattinger; Huy Riem Ha; Ferenc Follath; Stephan Krähenbühl
Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man.
British journal of clinical pharmacology 1998;45(4):355-9.
1997: S Kleinle; Ulrich N Wiesmann; andrea superti-furga; Stephan Krähenbühl; E Boltshauser; Jürg Reichen; S Liechti-Gallati
Detection and characterization of mitochondrial DNA rearrangements in Pearson and Kearns-Sayre syndromes by long PCR.
Human genetics 1997;100(5-6):643-50.
1997: Marc Forestier; Marc Solioz; F Isbeki; C Talos; Jürg Reichen; Stephan Krähenbühl
Hepatic mitochondrial proliferation in rats with secondary biliary cirrhosis: time course and mechanisms.
Hepatology (Baltimore, Md.) 1997;26(2):386-91.
1997: Huy Riem Ha; Ferenc Follath; Y Bloemhard; Stephan Krähenbühl
Determination of saquinavir in human plasma by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 1997;694(2):427-33.
1997: Lukas Krähenbühl; Jürg Reichen; C Talos; Stephan Krähenbühl
Benzoic acid metabolism reflects hepatic mitochondrial function in rats with long-term extrahepatic cholestasis.
Hepatology (Baltimore, Md.) 1997;25(2):278-83.
1997: Stephan Krähenbühl; J Reichen
Carnitine metabolism in patients with chronic liver disease.
Hepatology (Baltimore, Md.) 1997;25(1):148-53.
1996: H Kupferschmidt; T Langenegger; Stephan Krähenbühl
[Pericarditis in chronic inflammatory bowel disease: underlying disease or side effects of therapy? Clinical problem solving].
Schweizerische medizinische Wochenschrift 1996;126(50):2184-90.
1996: Karin Fattinger; Katharina M Rentsch; Peter J Meier Abt; heidi dazzi; Stephan Krähenbühl
Safety of liver donation after fatal intoxication with the tricyclic antidepressant trimipramine.
Transplantation 1996;62(9):1259-62.
1996: B Kind; Karin Fattinger; Stephan Krähenbühl; Peter J Meier Abt
[The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?].
Praxis 1996;85(46):1490-2.
1996: Stephan Krähenbühl; T Schäfer; U Wiesmann
Determination of the activities of the enzyme complexes of the electron transport chain in human fibroblasts.
Clinica chimica acta; international journal of clinical chemistry 1996;253(1-2):79-90.
1996: B Kind; Karin Fattinger; Stephan Krähenbühl; Peter J Meier Abt
[Clinicopharmacological case report (3). Drug-induced angioedema].
Praxis 1996;85(17):567-9.
1996: C Meier; C Hess; Peter J Meier Abt; Stephan Krähenbühl
[A clinical-pharmacological case (1). Action of cisapride (Prepulsid) on bladder function].
Praxis 1996;85(3):62-4.
1996: S Ruesch; Stephan Krähenbühl; S Kleinle; S Liechti-Gallati; T Schaffner; B Wermuth; J Weber; U N Wiesmann
Combined 3-methylglutaconic and 3-hydroxy-3-methylglutaric aciduria with endocardial fibroelastosis and dilatative cardiomyopathy in male and female siblings with partial deficiency of complex II/III in fibroblasts.
Enzyme & protein 1996;49(5-6):321-9.
1996: Stephan Krähenbühl
Carnitine metabolism in chronic liver disease.
Life sciences 1996;59(19):1579-99.
1995: Stephan Krähenbühl; C Talos; B H Lauterburg; Jürg Reichen
Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats.
Hepatology (Baltimore, Md.) 1995;22(2):607-12.
1995: Bruno Stieger; B O'Neill; Stephan Krähenbühl
Characterization of L-carnitine transport by rat kidney brush-border-membrane vesicles.
The Biochemical journal 1995;309 ( Pt 2)():643-7.
1995: S Berardi; Bruno Hagenbuch; E Carafoli; Stephan Krähenbühl
Characterization of the endogenous carnitine transport and expression of a rat renal Na(+)-dependent carnitine transport system in Xenopus laevis oocytes.
The Biochemical journal 1995;309 ( Pt 2)():389-93.
1995: Stephan Krähenbühl; U Marti; I Grant; P J Garlick; P E Ballmer
Characterization of mechanisms causing hypoalbuminemia in rats with long-term bile duct ligation.
Journal of hepatology 1995;23(1):79-86.
1995: Stephan Krähenbühl; G Mang; H Kupferschmidt; Peter J Meier Abt; M Krause
Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity.
Gut 1995;37(1):140-3.
1995: H H Kupferschmidt; Huy Riem Ha; W H Ziegler; Peter J Meier Abt; Stephan Krähenbühl
Interaction between grapefruit juice and midazolam in humans.
Clinical pharmacology and therapeutics 1995;58(1):20-8.
1995: Stephan Krähenbühl; B Sauter; H Kupferschmidt; M Krause; P A Wyss; Peter J Meier Abt
Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication.
The American journal of the medical sciences 1995;309(6):315-6.
1995: A Frenzer; P Schubarth; M Soucek; Stephan Krähenbühl
Disappearance of a large mediastinal pseudocyst in a patient with chronic alcoholic pancreatitis after total parenteral nutrition.
European journal of gastroenterology & hepatology 1995;7(4):369-71.
1994: Stephan Krähenbühl; S Fischer; C Talos; Jürg Reichen
Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria.
Hepatology (Baltimore, Md.) 1994;20(6):1595-601.
1994: Stephan Krähenbühl; C Talos; U Wiesmann; C L Hoppel
Development and evaluation of a spectrophotometric assay for complex III in isolated mitochondria, tissues and fibroblasts from rats and humans.
Clinica chimica acta; international journal of clinical chemistry 1994;230(2):177-87.
1994: R Friolet; Hans Hoppeler; Stephan Krähenbühl
Relationship between the coenzyme A and the carnitine pools in human skeletal muscle at rest and after exhaustive exercise under normoxic and acutely hypoxic conditions.
The Journal of clinical investigation 1994;94(4):1490-5.
1994: Stephan Krähenbühl; C Talos; Jürg Reichen
Mechanisms of impaired hepatic fatty acid metabolism in rats with long-term bile duct ligation.
Hepatology (Baltimore, Md.) 1994;19(5):1272-81.
1994: A Frenzer; T Gyr; H M Schaer; H Herren; Stephan Krähenbühl; M Schaer
[Triplet pregnancy with HELLP syndrome and transient diabetes insipidus].
Schweizerische medizinische Wochenschrift 1994;124(16):687-91.
1994: Patrice M Ambühl; P E Ballmer; Stephan Krähenbühl
[Fulminant hepatitis: pathogenesis, clinical aspects and management].
Schweizerische medizinische Wochenschrift 1994;124(9):368-80.
1994: Stephan Krähenbühl; C Talos; S Fischer; Jürg Reichen
Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria.
Hepatology (Baltimore, Md.) 1994;19(2):471-9.
1993: Stephan Krähenbühl
Alterations in mitochondrial function and morphology in chronic liver disease: pathogenesis and potential for therapeutic intervention.
Pharmacology & therapeutics 1993;60(1):1-38.
1993: T Herren; F Como; Stephan Krähenbühl; P A Wyss
[Therapy of acute salicylate poisoning].
Schweizerische medizinische Wochenschrift 1993;123(38):1775-83.
1993: Stephan Krähenbühl; Jürg Reichen
Decreased hepatic glucose production in rats with carbon tetrachloride-induced cirrhosis.
Journal of hepatology 1993;19(1):64-70.
1993: Stephan Krähenbühl; J Raisin; T Herren
[Malignant neuroleptic syndrome under metoclopramide and neuroleptics in anuria].
Schweizerische medizinische Wochenschrift 1993;123(26):1359-62.
1993: Stephan Krähenbühl; P Grass; A Surve; K Kutz; Jürg Reichen
Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease.
European journal of clinical pharmacology 1993;45(3):247-53.
1992: Stephan Krähenbühl; S Krähenbühl-Glauser; Jörg W Stucki; Peter Gehr; Jürg Reichen
Stereological and functional analysis of liver mitochondria from rats with secondary biliary cirrhosis: impaired mitochondrial metabolism and increased mitochondrial content per hepatocyte.
Hepatology (Baltimore, Md.) 1992;15(6):1167-72.
1992: Stephan Krähenbühl; Jörg W Stucki; Jürg Reichen
Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1992;15(6):1160-6.
1992: Stephan Krähenbühl; Jürg Reichen
Adaptation of mitochondrial metabolism in liver cirrhosis. Different strategies to maintain a vital function.
Scandinavian journal of gastroenterology. Supplement 1992;193():90-6.
1989: J Knuchel; Stephan Krähenbühl; Arthur Zimmermann; Jürg Reichen
Effect of secretin on bile formation in rats with cirrhosis of the liver: structure-function relationship.
Gastroenterology 1989;97(4):950-7.
1989: Stephan Krähenbühl; Peter J Meier Abt; Jürg Reichen
Taurocholate transport by liver plasma membrane vesicles is not altered in cirrhotic rats.
Journal of hepatology 1989;9(1):1-9.
1989: Stephan Krähenbühl; Jörg W Stucki; Jürg Reichen
Mitochondrial function in carbon tetrachloride-induced cirrhosis in the rat. Qualitative and quantitative defects.
Biochemical pharmacology 1989;38(10):1583-8.
1988: Stephan Krähenbühl; Jürg Reichen
Canalicular bile flow and bile salt secretion are maintained in rats with liver cirrhosis. Further evidence for the intact cell hypothesis.
Journal of hepatology 1988;7(1):63-71.